You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

News

Prospectus for Arjo AB (publ) published

November 10, 2017 Gothenburg, Sweden

Prospectus for Arjo AB (publ) published

Getinge’s wholly-owned subsidiary Arjo AB (publ) has prepared a prospectus regarding the admission to trading of the company’s shares of series B. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority. Similar to Getinge’s shares of series A, Arjo’s shares of series A will not be listed.

The prospectus can be obtained from Getinge and SEB and is available at Getinge’s website, www.getinge.com and at SEB’s website for prospectuses, www.sebgroup.com/prospectuses.

For more information:

Lars Mattsson, Getinge
Head of Investor Relations
Telephone: +46(0)10 335 00 43
E-mail: lars.mattsson@getinge.com

Kornelia Rasmussen, Arjo
Executive Vice President
Marketing Communication and Public Relations
Telephone: +46 (0)10 335 58 10
E-mail: kornelia.rasmussen@arjo.com

About Getinge
Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving everyday life for people, today and tomorrow. 
 

Teilen: